Print

Allenex AB Receives Part of €2.6M EU Grant in Collaboration With EUROSTAM  
2/1/2013 9:09:59 AM

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Allenex (STO:ALNX) announces that Allenex group company AbSorber, together with EUROSTAM, a consortium of European Transplant Centers, has been supported by a € 2.6 million grant as part of the European Commission 7th framework programme (FP7). This is part of an ongoing Europe-wide strategy to enhance transplantation of highly sensitized patients where risk of complication is high due to genetic mismatches. The main objective of the three year project is to determine the clinical value of implementing a Europe-wide acceptable HLA mismatch program to facilitate more as well as safer transplantations on highly sensitized patients all over Europe.
//-->